Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants

  • Protocol
  • Intervention

Authors

  • Kiran More,

    Corresponding author
    1. Princess Margaret Hospital and King Edward Hospital, Department of Neonatology, Subiaco, Western Australia, Australia
    Search for more papers by this author
  • Gayatri Athalye-Jape,

    1. Princess Margaret Hospital and King Edward Hospital, Department of Neonatology, Subiaco, Western Australia, Australia
    Search for more papers by this author
  • Shripada C Rao,

    1. King Edward Memorial Hospital for Women and Princess Margaret Hospital for Children, Centre for Neonatal Research and Education, Perth, Western Australia, Australia
    Search for more papers by this author
  • Sanjay K Patole

    1. King Edward Memorial Hospital, School of Paediatrics and Child Health, School of Women's and Infant's Health, University of Western Australia, Perth, Western Australia, Australia
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To assess the efficacy and safety of ETRA in the treatment of PPHN in full-term and late preterm infants.

  2. To assess the efficacy and safety of selective (which block only the ETA receptors) and non-selective (which block both ETA and ETB receptors) ETRA separately.